Css LLC Il boosted its holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 215.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 52,075 shares of the company’s stock after purchasing an additional 35,541 shares during the quarter. Css LLC Il’s holdings in BlackRock Health Sciences Term Trust were worth $750,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of BMEZ. Raymond James Financial Inc. purchased a new stake in shares of BlackRock Health Sciences Term Trust in the fourth quarter valued at about $10,869,000. Absolute Investment Advisers LLC acquired a new position in BlackRock Health Sciences Term Trust in the 4th quarter valued at about $3,941,000. CF Capital LLC purchased a new stake in BlackRock Health Sciences Term Trust during the 4th quarter valued at approximately $3,743,000. Wolverine Asset Management LLC lifted its position in BlackRock Health Sciences Term Trust by 496.1% during the 4th quarter. Wolverine Asset Management LLC now owns 187,617 shares of the company’s stock worth $2,702,000 after acquiring an additional 156,141 shares during the period. Finally, Bank of America Corp DE grew its stake in shares of BlackRock Health Sciences Term Trust by 10.9% in the 4th quarter. Bank of America Corp DE now owns 1,355,347 shares of the company’s stock valued at $19,517,000 after purchasing an additional 132,926 shares during the last quarter.
BlackRock Health Sciences Term Trust Price Performance
NYSE:BMEZ opened at $14.37 on Thursday. BlackRock Health Sciences Term Trust has a 12-month low of $12.58 and a 12-month high of $16.75. The stock’s 50 day simple moving average is $14.33 and its 200-day simple moving average is $15.14.
BlackRock Health Sciences Term Trust Cuts Dividend
BlackRock Health Sciences Term Trust Company Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Featured Stories
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Most Volatile Stocks, What Investors Need to Know
- $30B AI Opportunity: Will It Power Meta’s Next Surge?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Microsoft Could Rally as EU Antitrust Case Nears Resolution
- What Are the U.K. Market Holidays? How to Invest and Trade
- Intel Refocuses: NEX Sale and Foundry Pivot Signal New Era
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.